Run-Fen Cheng

1.1k total citations
38 papers, 757 citations indexed

About

Run-Fen Cheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Run-Fen Cheng has authored 38 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Run-Fen Cheng's work include Cancer-related molecular mechanisms research (6 papers), Cancer-related gene regulation (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Run-Fen Cheng is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Cancer-related gene regulation (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Run-Fen Cheng collaborates with scholars based in China, United States and Ethiopia. Run-Fen Cheng's co-authors include Xiulan Zhao, Lisha Qi, Baocun Sun, Baocun Sun, Zhaoxiang Ye, Fangyuan Qu, Zhiyong Liu, Xueyi Dong, Qiang Gu and Ying Liu and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Run-Fen Cheng

38 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Run-Fen Cheng China 16 425 204 168 164 149 38 757
Marta Sesé Spain 10 444 1.0× 173 0.8× 232 1.4× 55 0.3× 94 0.6× 18 742
Andreas Josefsson Sweden 18 340 0.8× 257 1.3× 222 1.3× 89 0.5× 456 3.1× 38 935
Ling‐Yuh Huw United States 15 254 0.6× 273 1.3× 142 0.8× 81 0.5× 81 0.5× 26 654
Yolanda Ruano Spain 13 314 0.7× 147 0.7× 147 0.9× 39 0.2× 111 0.7× 40 712
Zorka Milovanović Serbia 17 241 0.6× 261 1.3× 119 0.7× 68 0.4× 115 0.8× 55 707
Andreas Schnelzer Germany 13 525 1.2× 338 1.7× 185 1.1× 94 0.6× 97 0.7× 28 1.1k
S. Streit Germany 7 481 1.1× 364 1.8× 130 0.8× 110 0.7× 138 0.9× 8 823
Hanhua Huang United States 9 595 1.4× 182 0.9× 262 1.6× 80 0.5× 95 0.6× 14 869

Countries citing papers authored by Run-Fen Cheng

Since Specialization
Citations

This map shows the geographic impact of Run-Fen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run-Fen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run-Fen Cheng more than expected).

Fields of papers citing papers by Run-Fen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run-Fen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run-Fen Cheng. The network helps show where Run-Fen Cheng may publish in the future.

Co-authorship network of co-authors of Run-Fen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Run-Fen Cheng. A scholar is included among the top collaborators of Run-Fen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Run-Fen Cheng. Run-Fen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xun, Jing, Botao Wang, Xiaolin Jiang, et al.. (2024). RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4/PI3K/AKT signaling. Acta Histochemica. 126(5-7). 152190–152190. 2 indexed citations
2.
Zhang, Yanhui, Baohui Ju, Run-Fen Cheng, Tingting Ding, & Jianghua Wu. (2024). PD-L1 expression and immune infiltration across molecular subtypes of endometrial cancer: An integrative-analysis of molecular classification and immune subtypes. Human Pathology. 154. 105704–105704. 1 indexed citations
3.
Zhang, Yanhui, Run-Fen Cheng, Tingting Ding, & Jianghua Wu. (2024). Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases. Translational Lung Cancer Research. 13(12). 3590–3602. 2 indexed citations
4.
Sun, Huizhi, Run-Fen Cheng, Danfang Zhang, et al.. (2023). MIF promotes cell invasion by the LRP1-uPAR interaction in pancreatic cancer cells. Frontiers in Oncology. 12. 1028070–1028070. 7 indexed citations
5.
Gao, Yanan, Yi Pan, Ye Luo, Run-Fen Cheng, & Qiong-Li Zhai. (2023). Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases. Annals of Diagnostic Pathology. 67. 152221–152221. 2 indexed citations
6.
Cheng, Run-Fen, et al.. (2023). Paeonol Inhibits Glioma Growth In Vivo and In Vitro by Inducing Apoptosis and Cell Cycle Arrest. Revista Brasileira de Farmacognosia. 33(3). 534–542. 4 indexed citations
7.
Cheng, Run-Fen, Na Che, Yalei Wang, et al.. (2023). High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma. Scientific Reports. 13(1). 6957–6957. 2 indexed citations
8.
Li, Lifang, Xuefei Wang, Kai Hu, et al.. (2023). ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression. Oncogene. 42(27). 2166–2182. 1 indexed citations
9.
Liu, Tieju, Jing Mo, Xiaoyu Bai, et al.. (2022). LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression. Journal of Gastroenterology. 57(10). 784–797. 3 indexed citations
10.
Sun, Huizhi, Jing Mo, Run-Fen Cheng, et al.. (2022). ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment. Cancer Biology and Medicine. 19(11). 1598–1616. 7 indexed citations
11.
Zhang, Yanhui, Run-Fen Cheng, Danfang Zhang, et al.. (2022). Spatial maps of hepatocellular carcinoma transcriptomes highlight an unexplored landscape of heterogeneity and a novel gene signature for survival. Cancer Cell International. 22(1). 57–57. 18 indexed citations
12.
Zuo, Duo, Yongzi Chen, Xinwei Zhang, et al.. (2021). Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma. Cancer Biology and Medicine. 19(7). 1029–1046. 8 indexed citations
13.
Sun, Huizhi, Chongbiao Huang, Yuhong Guo, et al.. (2021). Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer. Cancer Biology and Medicine. 18(2). 616–630. 32 indexed citations
14.
Wu, Jianghua, Yanhui Zhang, Tingting Ding, et al.. (2019). Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas. Endocrine Pathology. 31(1). 39–45. 6 indexed citations
15.
Chen, Lu, Hui Fu, Yi Luo, et al.. (2017). cPLA2α mediates TGF-β-induced epithelial–mesenchymal transition in breast cancer through PI3k/Akt signaling. Cell Death and Disease. 8(4). e2728–e2728. 53 indexed citations
16.
Zhu, Xiaolei, Huan Jin, Xianxian Wu, et al.. (2017). Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis. Biochemical and Biophysical Research Communications. 486(2). 571–576. 17 indexed citations
17.
Cheng, Run-Fen, et al.. (2015). Classification of colon cancer based on the expression of randomly selected genes. Genetics and Molecular Research. 14(4). 12628–12635. 2 indexed citations
18.
Yue, Dongsheng, Hui Li, Juanjuan Che, et al.. (2015). EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. PLoS ONE. 10(7). e0132134–e0132134. 15 indexed citations
19.
Qi, Lisha, et al.. (2014). Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. Journal of Experimental & Clinical Cancer Research. 33(1). 107–107. 99 indexed citations
20.
Sun, Baocun, et al.. (2014). Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. Journal of Experimental & Clinical Cancer Research. 33(1). 107–107. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026